Stocks and Investing Stocks and Investing
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022

Joseph Schwartz Maintained (SPRB) at Hold with Decreased Target to $3 on, Mar 16th, 2022


Published on 2024-10-27 20:06:19 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Spruce Biosciences, Inc." (SPRB) at Hold with Decreased Target from $5 to $3 on, Mar 16th, 2022.

Joseph has made no other calls on SPRB in the last 4 months.



There are 6 other peers that have a rating on SPRB. Out of the 6 peers that are also analyzing SPRB, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Tuesday, November 23rd, 2021


These are the ratings of the 5 analyists that currently disagree with Joseph


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $9 on, Tuesday, March 15th, 2022
  • Aydin Huseynov of "Ladenburg Thalmann" Initiated at Strong Buy and Held Target at $6 on, Tuesday, March 8th, 2022
  • Hartaj Singh of "Oppenheimer" Initiated at Buy and Held Target at $15 on, Friday, December 17th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $6 on, Tuesday, November 16th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, November 16th, 2021